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SUMMARY
Wnt/b-catenin activation in adult epidermis can
induce new hair follicle formation and tumor devel-
opment. We used lineage tracing to uncover the
relative contribution of different stem cell popula-
tions. LGR6+ and LRIG1+ stem cells contributed
to ectopic hair follicles formed in the sebaceous
gland upon b-catenin activation, whereas LGR5+
cells did not. Lgr6, but not Lrig1 or Lgr5, was
expressed in a subpopulation of interfollicular
epidermal cells that were competent to form new
hair follicles. Oncogenic b-catenin expression in
LGR5+ cells led to formation of pilomatricomas,
while LRIG1+ cells formed trichoadenomas and
LGR6+ cells formed dermatofibromas. Tumor for-
mation was always accompanied by a local in-
crease in dermal fibroblast density and transient
extracellular matrix remodeling. However, each tu-
mor had a distinct stromal signature in terms of im-
mune cell infiltrate and expression of CD26 and
CD44. We conclude that compartmentalization of
epidermal stem cells underlies different responses
to b-catenin and skin tumor heterogeneity.
INTRODUCTION
Multiple epidermal stem cell subpopulations in adult mouse skin
have been identified over the last decade (Kretzschmar and
Watt, 2014; Solanas and Benitah, 2013). Although they tend to
be competent to give rise to all the different epidermal lineages
following transplantation, wounding, or genetic modification,
under steady-state conditions, they maintain the epidermis in a
compartmentalized manner (Page et al., 2013; Watt and Jen-
sen, 2009). Stem cells in the lower pilosebaceous unit (PSU)
comprising the hair bulge and germ (responsible for hair regen-
eration) express Krt19, CD34, Lgr5, and Gli1 (Blanpain et al.,
2004; Brownell et al., 2011; Jaks et al., 2008). Stem cells in the
upper PSU, consisting of the hair follicle (HF) isthmus, junctional
zone, infundibulum, and sebaceous gland (SG), express Lrig1,
Lgr6, and Plet1 (Jensen et al., 2009; Nijhof et al., 2006; Page
et al., 2013; Snippert et al., 2010). Previous studies have identi-
fied Lgr6-expressing cells in the interfollicular epidermis (IFE)
(Liao and Nguyen, 2014; Page et al., 2013) and a recent study
has shown that they have stem cell characteristics (F€ullgrabe
et al., 2015).
The Wnt pathway plays a crucial role in epidermal develop-
ment, homeostasis, and cancer (Blanpain et al., 2007; Lim and
Nusse, 2013; Watt and Collins, 2008). b-Catenin activation is
required for HF morphogenesis during embryonic development
and for the growth phase of the hair growth cycle in adult skin
(Huelsken et al., 2001; Lim et al., 2013; Lowry et al., 2005; Nie-
mann et al., 2002). Recent work suggests that canonical Wnt
signaling is also required for IFE stem cell activation during adult
homeostasis, as loss of b-catenin in this compartment causes
decreased proliferation of basal layer keratinocytes and IFE thin-
ning (Choi et al., 2013; Lim et al., 2013). In adult skin, transient
epidermal activation of b-catenin induces ectopic HFs in SG,
HF, and IFE (Baker et al., 2010; Lo Celso et al., 2004; Silva-Var-
gas et al., 2005). However, the different regions of the skin exhibit
differential sensitivity to b-catenin, with SG being most sensitive
and the HF bulge being highly insensitive (Baker et al., 2010; De-
schene et al., 2014; Silva-Vargas et al., 2005).
In addition to its role in normal epidermis, deregulated Wnt
signaling is a feature of epidermal tumors (Klaus and Birchmeier,
2008; Watt and Collins, 2008). In human skin, oncogenic activa-
tion of b-catenin occurs in HF tumors known as pilomatricomas
(Chan et al., 1999), while mutations in the LEF1 transcription fac-
tor that prevent binding of b-catenin are associated with SG
tumors (Takeda et al., 2006). Consistent with the human studies,
in mouse, sustained activation of b-catenin in all stem cell com-
partments that express keratin 14 (Krt14) results in pilomatrico-
mas and trichofolliculomas (Gat et al., 1998; Lo Celso et al.,
2004; Van Mater et al., 2003; Watt and Collins, 2008), while
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expression ofDNLef1 results in SG tumors (Niemann et al., 2002,
2007). In addition, epidermal deletion of b-catenin causes
regression of squamous cell carcinomas (SCCs) (Beronja et al.,
2013; Lo Celso et al., 2004; Malanchi et al., 2008). Formation
of basal cell carcinomas (BCCs) has also been shown to be
dependent on b-catenin activation, either in response to acti-
vating mutations in the Hedgehog signaling pathway (Youssef
et al., 2010, 2012) or in the absence of vitamin D receptor
signaling (Pa´lmer et al., 2008).
The differential sensitivity of different regions of the epidermis
to forming new HFs on transient b-catenin activation and the
diversity of epidermal tumor types associated with oncogenic
b-catenin mutations raise the question of whether different
epidermal stem cell populations exhibit different responses to
b-catenin. To investigate this, we activated b-catenin in LGR5+,
LGR6+, and LRIG1+ stem cells and examined the consequences.
Our results show that the outcome of b-catenin activation is
specified by the compartmental origin of the initiating epidermal
stem cells and correlates with distinct changes in the underlying
dermis.
RESULTS
Expression of Lgr5, Lgr6, and Lrig1 in Adult Mouse
Epidermis
We used Lgr5EGFPiresCreERT2 (Lgr5 KI), Lgr6EGFPiresCreERT2
(Lgr6 KI), and Lrig1EGFPiresCreERT2 (Lrig1 KI) mouse lines to
target each stem cell compartment (Figure 1A). We collected
tail skin from adult mice and analyzed epidermal EGFP expres-
sion to confirm the location of cells expressing each marker. As
reported previously, Lgr5-EGFP+ cells were found in the cycling
portion of both telogen and anagen HFs (Figure 1B) (Jaks et al.,
2008). Lrig1-EGFP+ cells were mainly found in the HF junctional
zone (Figure 1C) but were also found along the periphery of the
SG, in the late telogen hair germ, and in the anagen hair bulb
and outer root sheath, in agreement with previous publications
(Jensen et al., 2009; Page et al., 2013). Lgr6-EGFP expression
in the HF isthmus (Snippert et al., 2010), SG, and lower HF (Fig-
ure 1D) was also confirmed (Liao and Nguyen, 2014; Page
et al., 2013). Significant overlap between LRIG1 and Lgr5-
EGFP expression was found in the lower HF, particularly in
Figure 1. Epidermal Expression and Lineage Tracing of Lgr5, Lrig1, and Lgr6 during Adult Homeostasis
(A) Schematic diagram of stem cell marker expression in the epidermis.
(B–E) Detection of Lgr5-EGFP (green in B), Lrig1-EGFP (green in C), Lgr6-EGFP (green in D and E), and K14 (red) or LRIG1 (red) in tail epidermal whole mounts of the
respective adult KI mice. Whole mounts were counterstained with phalloidin to label F-actin (blue). Single-color images are shown for some markers in grayscale.
(F) Schematic representation of the genetic elements for lineage tracing during adult homeostasis (control) and the experimental setup.
(G–I) Tail epidermal whole mounts of Lgr5 KI/R26R-tdTomato (G), Lrig1 KI/R26R-tdTomato (H), and Lgr6 KI/R26R-tdTomato (I) mice collected 2 weeks after
4-OHT treatment, stained with anti-tdTomato (red), and counterstained with DAPI to label nuclei (blue). Single-color images for tdTomato are shown in grayscale.
Bu, bulge; DP, dermal papilla; HG, hair germ; IFE, interfollicular epidermis; JZ/IS, junctional zone/isthmus; INF, infundibulum; SG, sebaceous gland. Dashed lines
demarcate HF, SG, and ectopic HFs. Scale bars, 100 mm.
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anagen follicles (Figure 1B). LRIG1 was co-expressed with Lgr6-
EGFPat the junction between the isthmusand the junctional zone
of the upper HF and the periphery of the SG (Figure 1E).
Scattered Lgr6-EGFP+ cells were also found in tail IFE (Fig-
ure 1D). Mouse tail IFE contains two distinct lineages of kera-
tinocytes that form the parakeratotic scales and orthokeratotic
interscales (Gomez et al., 2013). Immunostaining for the inter-
scale markers K10 and Filaggrin (FLG) (Gomez et al., 2013)
established that Lgr6-EGFP+ IFE cells were largely confined to
the interscale IFE and absent from the scale IFE (Figures S1A
and S1B).
For genetic lineage tracing (Kretzschmar and Watt, 2012), we
bred KI mice with mice carrying the R26R-tdTomato reporter
(Figure 1F). As a control for leakiness of the CreER constructs,
some mice were treated with acetone in the absence of 4-hy-
droxy-tamoxifen (4-OHT) (Figure S2). In acetone-treated Lgr5
KI/R26R-tdTomato mice, patches of tdTomato+ cells were de-
tected in the lower HF in the absence of 4-OHT (Figure S2A).
Some leakiness was observed in hair germ, junctional zone,
infundibulum, and sebaceous duct of acetone-treated Lrig1
KI/R26R-tdTomato control mice (Figure S2B). Acetone-only-
treated Lgr6 KI/R26R-tdTomato mice showed very little activa-
tion of Cre (Figure S2C). Overall, the leakiness was minimal
and specific to the expected regions of Cre expression.
When Lgr5 KI/R26R-tdTomato mice were treated with one
dose of 4-OHT and examined 2 weeks later, tdTomato+ cells
were found in the hair germ and bulge (Figure 1G), as reported
previously (Jaks et al., 2008). In Lrig1 KI/R26R-tdTomato mice,
tdTomato+ cells were present in the lower SG, HF junctional
zone, and infundibulum (upper PSU), as well as in the hair
germ (Figure 1H), again confirming previous observations
(Page et al., 2013). In contrast, the progeny of LGR6+ stem cells
contributed to the upper HF, SG, and IFE (Figure 1I), confirming
the results for back skin previously obtained by Snippert et al.
(2010). In the tail IFE, tdTomato+ progeny of Lgr6-EGFP+ cells
were largely confined to the interscale IFE, which expresses ker-
atin 2 (K2) in addition to K10 and Filaggrin (Figure S1D) (Gomez
et al., 2013), but absent from the K31+ scale IFE (Figure S1E).
tdTomato+ progeny of Lgr6-expressing cells were present in all
IFE layers and were readily detectable even 6 months after
4-OHT treatment (Figures S1D and S1F), suggesting that LGR6
marks interscale IFE stem cells.
These results confirm previous observations that LGR5,
LGR6, and LRIG1 are markers of distinct epidermal subpopula-
tions. In addition, they establish LGR6 as a marker to distinguish
interscale from scale stem cells.
Stem Cell Origins of Ectopic Hair Follicles
To study the contribution of each stem cell population to ectopic
HF formation, we bred KI mice with DK5DNb-cateninERt
(DK5b-catER) transgenic mice (Baker et al., 2010) carrying the
R26R-tdTomato reporter (Figure 2A). Adult mice were treated
with one dose of 4-OHT to simultaneously induce Cre and
ectopic HF formation (Figure 2B). Tissue was collected 1 or
2 weeks following 4-OHT application, by which time ectopic
HF formation was evident (Figures 2B and S3B). Activation of
the DK5b-catER transgene stimulated anagen of existing HFs
and induced conversion of SGs into ectopic HFs (Figure S3).
Cells in ectopic HFs and the base of anagen HFs expressed
CDP, an inner root sheath/hair bulb marker, as reported previ-
ously (Figures 2C–2E) (Baker et al., 2010; Lo Celso et al.,
2004). CDP expression was not detected in SGs of 4-OHT-
treated mice lacking the DK5b-catER transgene, but CDP was
expressed in some cells of the hair germ (Figure S4A).
In 4-OHT-treated Lgr5 KI/R26R-tdTomato/DK5b-catER mice,
robust tdTomato labeling was detected in the lower hair bulge
and early anagen bulbs (Figure 2C). tdTomato+ progeny of
Lgr5-expressing cells were present in 11% of ectopic HFs
(Figure 2F), where they were confined to the inner cell layers
(Figure S4B). Some EGFP+ cells were detected in ectopic HFs,
consistent with Lgr5 being a Wnt target gene (Figure 2G).
Over 90% of ectopic HFs in Lrig1 KI/R26R-tdTomato/
DK5b-catER epidermis contained clusters of tdTomato+ cells
(Figures 2D and 2F). Ectopic HFs were also strongly positive
for Lrig1-EGFP (Figure 2G). Almost 100% of ectopic HFs arising
from SGs in Lgr6 KI/R26R-tdTomato/DK5b-catER mice were
strongly labeled with tdTomato (Figures 2E and 2F), and Lgr6-
EGFP+ cells were found in the ectopic HFs arising from the SG
(Figure 2G). Lgr6-EGFP and LRIG1 were both expressed in
ectopic HFs arising in the IFE (Figure 2I).
Although in DK5b-catER transgenic mice ectopic HFs arise
predominantly from the SG, some ectopic HFs also form in the
tail IFE (Baker et al., 2010), even after a single dose of 4-OHT
(Figure 2H). The IFE ectopic HFs were derived from LGR6+, but
not from LRIG1+ or LGR5+ stem cells of the HF (Figure 2H;
data not shown). tdTomato labeling in IFE ectopic HFs was not
continuous with the PSU (Figure 2H), which supports the
concept that the ectopic growths were of IFE origin, as previ-
ously reported (Silva-Vargas et al., 2005).
Collectively, these data demonstrate that ectopic HFs arising
from the SG are not derived from Lgr5-expressing stem cells
but originate from stem cell pools expressing Lrig1 and Lgr6
that reside at, or in close proximity to, the sites of ectopic HF
formation (Figure 2J). Ectopic HFs often comprised a mixture
of tdTomato-positive and negative cells (Figures 2E–2G), indi-
cating a polyclonal origin. LGR6+ IFE cells contributed to ectopic
HFs arising from the IFE, whereas LRIG1+ and LGR5+ HF cells
did not (Figure 2J).
b-Catenin Activation in Different Stem Cell Populations
Results in Different Tumor Types
To study the contribution of different stem cell populations to
b-catenin-induced epidermal tumors, we generated KI/R26R-
tdTomato/Ctnnb1lox(ex3)/+ mice and treated adult animals with a
single dose of 4-OHT. Cre-dependent deletion of exon 3 of
Ctnnb1 (Ctnnb1lox(ex3)) results in constitutive activation of b-cat-
enin in the respective stem cell populations and their progeny
(Harada et al., 1999) (Figures 3A and 3B). Control mice that
lacked the Ctnnb1 mutant allele did not exhibit any abnormal
phenotypes (Figures 3C–3F).
Lgr5 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ mice entered anagen
2 weeks following 4-OHT application, and pilomatricomas,
benign HF skin tumors (Chan et al., 1999; Lo Celso et al.,
2004; Merrill et al., 2001), developed within 4 weeks (Figures
3A–3I). The upper portions of the HF, SGs, and IFE were unaf-
fected by the lesions arising in the lower HF (Figures 3D–3M).
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Figure 2. Lineage Tracing of Ectopic Hair Folli-
cles
(A and B) Schematic representation of the genetic ele-
ments for lineage tracing (A) and experimental setup (B).
(C–E and G–I) Tail epidermal whole mounts collected
2 weeks after 4-OHT treatment and stained with anti-
tdTomato, anti-CDP, and anti-GFP, as indicated.
Boxed regions in (C)–(E) are also shown at higher
magnification. (C and G) Lgr5 KI/R26R-tdTomato/
DK5DNb-cateninER; (D and G) Lrig1 KI/R26R-
tdTomato/DK5DNb-cateninER; (E, G, H, and I) Lgr6 KI/
R26R-tdTomato/DK5DNb-cateninER. Whole mounts
were counterstained with DAPI to label nuclei or with
phalloidin to label F-actin (blue). Single-color images for
some markers are shown in grayscale. Dashed lines
demarcate HF, SG and ectopic HFs. Individual ectopic
HFs are indicated with arrowheads.
(F) % pilosebaceous units (PSUs) with tdTomato+
ectopic HFs (10–25 PSUs per mouse, n = 3). Data are
mean ± SEM. *p < 0.05.
(J) Schematic showing the cellular origins of ectopic HF
(eHF).
Bu, bulge; DP, dermal papilla; HG, hair germ; IFE, in-
terfollicular epidermis; JZ/IS, junctional zone/isthmus;
INF, infundibulum; SC, stem cell. Scale bars represent
100 mm (C–E and G) and 50 mm (H and I).
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Eight weeks following 4-OHT application, most HFs had re-
entered telogen, but pilomatricomas persisted, extending into
the skin adipocyte layer (Figures 3F, 3H, and 3I; 50 PSUs scored
from two mice). Mice carrying the mutant allele of Ctnnb1 had to
be killed 8 weeks following 4-OHT induction due to weight loss.
The mice had developed small intestinal tumors most likely
caused by 4-OHT ingestion activating the mutant allele in Lgr5-
expressing cells of the gastrointestinal (GI) tract (data not shown)
(Barker et al., 2009).
In Lgr5 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ mutant and Lgr5
KI/R26R-tdTomato/Ctnnb1+/+ control skin tdTomato+ cells
were only present in the lower HF (bulge and hair germ) and
were absent from the permanent portion of the HF (Figures 3J
and 3K). No Lgr5-EGFP+ or tdTomato+ cells were found in the
dermis (Figures 3J and 3K). Immunostaining for b-catenin and
LEF1 indicated thatWnt signaling was restricted to anagen bulbs
and HF tumors (Figures 3L and 3M; data not shown). HF tumors
were strongly positive for the proliferation marker Ki67 (Fig-
ure S5A) and expressed the HF differentiation markers K17
and K31 (Figures S5B and S5C).
In contrast to Lgr5 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ mice,
adult Lrig1 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ mice (Figures 4A
and 4B) developed a hyperplastic, highly keratinized junctional
zone and a thickening of the IFE within 4 weeks following
4-OHT application (Figures 4C, 4F, and 4G). The phenotype
became progressivelymore severe over the subsequent 6weeks
after 4-OHT treatment, affecting the entire HF (Figures 4D–4G).
The lesions resembled human trichoadenomas, a rare benign
follicular tumor with cornifying cysts (Kurokawa et al., 2005;
Shimanovich et al., 2010), with a high proportion of undifferenti-
ated cells and an infiltrate of immune cells including neutrophils
(Figure S6A). Lrig1 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ mice had
to be killed within 6 weeks of the start of the experiment, as they
developed GI tumors, consistent with Lrig1 expression in the in-
testinal epithelium (Powell et al., 2012; Wong et al., 2012).
Lineage tracing revealed that at 4 weeks tdTomato+ cells were
mostly restricted to the tumors, the upper portion of the HF and
IFE (Figures 4H and 4I). In agreement with previous publications,
cells positive for tdTomato and Lrig1-EGFP were also found in
the dermis (Driskell et al., 2013; Gomez et al., 2013) (Figures
4H and 4I). b-Catenin and LEF1 expression was highly upre-
gulated in the hyperplastic HF junctional zone and tumors of
Ctnnb1 mutant skin (Figure 4J). However, nuclear b-catenin
Figure 3. Oncogenic Activation of b-Catenin in LGR5+ Stem Cells
(A) Schematic representation of the genetic elements for lineage tracing and
b-catenin activation.
(B) Experimental setup.
(C–F and J–M) Back skin sections of Lgr5 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+
mutant and control (Ctrl) mice 4 (C, D, J–M) and 8weeks after 4-OHT treatment
(E and F). (C–F) H&E staining. (J–M) Immunolabeled with the antibodies indi-
cated and counterstained with DAPI to label nuclei (blue). Grayscale images of
the same fields are also shown. Dashed lines denote epidermal-dermal
boundaries. Insert shows higher magnification view of selected area. Scale
bars, 200 mm.
(G and H) Quantification of lesions in all epidermal subcompartments (G) and
lower HF phenotypes (H). Data are means ± SD (25 PSUs scored per mouse;
4 weeks, n = 3; 8 weeks, n = 2).
(I) Schematic of phenotype progression over time. Scale bars, 200 mm.
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and LEF1 were not detected in the IFE or tumor stroma, suggest-
ing a lack of significant Wnt/b-catenin activity in these compart-
ments (Figure 4J).
Expression of K14 extended into the suprabasal layers of back
skin IFE and cysts, while expression of the differentiation
markers K10 and involucrin (IVL) was perturbed in the suprabasal
layers (Figures S6B and S6C), indicating abnormal terminal
differentiation, as observed in human trichoadenoma (Kurokawa
et al., 2005). Pronounced expression of cyclin D1 and Ki67 in the
trichoadenoma cysts (Figures S6D and S6E) confirmed hy-
perplasia, again consistent with the human lesions (Kurokawa
et al., 2005; Shimanovich et al., 2010).
Within 4 weeks of 4-OHT treatment (Figures 5A and 5B),
Lgr6 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ mutant skin developed
ectopic HFs from the SG and IFE and exhibited expansion of
the upper portion of the HF (Figures 5C, 5D, 5H–5J, and 5L).
By 12 weeks, cysts had formed in the SG and upper and lower
HF (Figures 5F–5L). The IFE of Lgr6 mutant skin progressively
developed irregular invaginations into the underlying dermis
resembling the epithelial compartment of a benign human skin
Figure 4. Oncogenic Activation of b-Catenin in LRIG1+ Stem Cells
(A) Schematic representation of genetic elements for lineage tracing and b-catenin activation.
(B) Experimental setup.
(C–E and H–J) Back skin sections of Lrig1 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ mutant and control (Ctrl) mice 4 weeks (unless stated otherwise) after 4-OHT
application, stainedwith H&E (C–E) or antibodies to themarkers indicated, with DAPI counterstain to label nuclei (blue) (H–J). Grayscale images for the same fields
are also shown (H–J). Dashed lines and arrowheads denote epidermal-dermal boundaries. Inserts show higher magnification views of selected areas. Scale bars
represent 200 mm, except (J.I)–(J.IV) (50 mm).
(F) Quantification of lesions in all dorsal epidermal subcompartments with abnormalities. 25 PSUs per mouse (n = 3). Data are means ± SEM.
(G) Schematic of phenotype progression over time.
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lesion called dermatofibroma (or benign fibrous histiocytoma)
(Figures 5G, 5I, and 5L). Dermatofibroma is characterized by
pronounced epidermal hyperplasia and occasional HF budding
that mimics superficial BCCs (Zelger et al., 2004). At four weeks,
the HF outgrowths in mouse skin resembled embryonic hair
placodes and hair germs (Figures 5D and 5E). Some developed
Figure 5. Oncogenic Activation of b-Catenin in LGR6+ Stem Cells
(A) Schematic representation of genetic elements for lineage tracing and oncogenic b-catenin activation in LGR6+ stem cells.
(B) Experimental setup.
(C, D, F, G, M, and N) Back skin sections of Lgr6 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ mutant and control (Ctrl) mice 4 weeks (unless stated otherwise) after 4-OHT
application, stained with hematoxylin and eosin (H&E; C, D, F, and G) or antibodies to the markers indicated, with DAPI counterstain to label nuclei (blue) (M and
N). Grayscale images for the same fields are also shown. Dashed lines denote epidermal-dermal boundaries. Inserts show higher magnification views of selected
areas.
(E) E15.5 sections of wild-type embryonic skin stained with hematoxylin and eosin.
(H–K) Quantification of lesions in all dorsal epidermal subcompartments with abnormalities (H) and specific abnormalities in IFE (I), SG (J), and HF (K). 25 PSUs per
mouse (n = 3). Data are means ± SEM.
(L) Schematic of phenotype progression over time.
Scale bars represent 200 mm, except (E) (100 mm).
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into small HFs with associated SGs (Figure S7A) but progressed
into disorganized lesions (Figure 5G).
Expression of Lgr6-EGFP and tdTomato was compartmental-
ized in Ctnnb1 mutant skin, with cells positive for either or both
markers being present in the IFE and hyperplastic HF junctional
zone as well as ectopic HFs arising from the SG (Figure 5M). In
Ctnnb1 mutant skin, b-catenin, LEF1, and cyclin D1 expression
was highly upregulated in cells in tumors and ectopic HFs (Fig-
ures 5N and S7B). IFE dysplasias were also strongly positive
for the proliferation marker Ki67 and showed defects in differen-
tiation (Figures S7C and S7D). Infundibular cysts and HF buds
arising from the IFE were positive for the HF lineage marker
K17 (Figure S7E).
These experiments show that sustained activation of b-cate-
nin in different stem cell compartments results in tumors that
differ in location and type.
Distinct Dermal Responses to Compartmentalized
Stabilization of Epidermal b-Catenin
Sustained activation of b-catenin throughout the basal layer
of adult epidermis reprograms the underlying dermis to a
neonatal state, characterized by an increase in fibroblast
density and extensive extracellular matrix (ECM) remodel-
ing (Collins et al., 2011). To discover whether, in addition to
inducing different types of tumors, b-catenin activation in
different stem cell subpopulations had different effects on
the dermis, we first evaluated skin for fibroblast density by
labeling for vimentin and for ECM remodeling by labeling for
CD44 and staining with Herovici. CD44 is a b-catenin target
gene (Wielenga et al., 1999) and the major cell-surface recep-
Figure 6. Differential Stromal Responses to
Compartmentalized Epidermal Activation of
b-Catenin
(A and B) Back skin sections of Ctnnb1lox(ex3)/+
mutant and control (Ctrl) mice indicated, 4 weeks
(unless stated otherwise) after 4-OHT application.
(A) Stained with anti-K14 (green) and anti-vimentin
(VIM; red), with DAPI counterstain (blue). (B)
Stained with Herovici dye to visualize immature
collagen (light blue) and mature collagen (pink).
Dashed lines and arrowheads denote epithelial-
stromal boundaries. Scale bars, 200 mm.
tor for hyaluronic acid (hyaluronan), a
key ECM component (Edward et al.,
2005). Herovici is a histochemical dye
that stains highly crosslinked, mature
collagen fibers pink and stains fine,
immature collagen fibrils light blue
(Collins et al., 2011).
Pilomatricomas resulting from Ctnnb1
activation in Lgr5-expressing stem cells
were surrounded by an increased den-
sity of vimentin+ fibroblasts, while fibro-
blast density in the rest of the skin
was unaffected (Figure 6A). Conversely,
when stabilized b-catenin was expressed
using the Lrig1 KI and Lgr6 KI mouse
models, only the upper layers of the dermis exhibited an
increased density of fibroblasts (Figure 6A).
At 4 weeks, back skin of Lgr5 KI/R26R-tdTomato/
Ctnnb1lox(ex3)/+ mutant mice showed comprehensive dermal
ECM remodeling and CD44 expression in the lower dermis sur-
rounding the pilomatricomas, while the upper dermis contained
only mature collagen (Figures 6B and S5D). By 8 weeks, the
entire dermis contained mature collagen (stained in pink), even
though the tumors persisted (Figure 6B).
Activation of the Ctnnb1 mutant using the Lrig1 KI and Lgr6
KI mouse models stimulated ECM remodeling initially only
around hyperplastic sites (Figure 6B). As the tumor lesions
progressed in the back skin of 4-OHT-treated Lrig1 KI/
R26R-tdTomato/Ctnnb1lox(ex3)/+ mice, collagen was compre-
hensively remodeled and the dermis was almost entirely filled
with compact immature collagen characteristic of tumor
stroma (Figure 6B). CD44 expression in fibroblasts was
confined to the areas surrounding the tumors but was also
highly upregulated in the hyperplastic epidermal regions of
the tumor itself (Figure S6F). In Lgr6 KI/R26R-tdTomato/
Ctnnb1lox(ex3)/+ skin, the dermis underlying IFE dysplasias
and surrounding upper pilosebaceous cysts stained light
blue with Herovici, indicating the presence of immature
collagen fibrils (Figure 6B). By 8 weeks, almost the entire
dermal ECM contained immature collagen (Figure 6B). Again,
CD44 expression was selectively upregulated in the fibro-
blasts adjacent to tumors (Figure S7F).
We also examined dermal expression of CD45 and CD26.
CD45 is expressed by infiltrating immune cells (Arwert et al.,
2012a; Leibl et al., 1985). CD26, a T cell activation antigen also
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known as dipeptidyl peptidase-4 (DPP4), is upregulated in hy-
perproliferative epidermis and in dermal fibroblasts during
wounding and chronic inflammation but is downregulated in
the stroma of epidermal tumors (Arwert et al., 2012b; Morimoto
and Schlossman, 1998).
In mice carrying the Lgr5 KI and Ctnnb1 mutant alleles, no
differences in expression of CD26 and CD45 were found at
any time up to 8 weeks following 4-OHT treatment (Figures
7A and 7B). When the Ctnnb1 activating mutation was induced
in LRIG1+ stem cells, CD26 was highly upregulated in
epidermal keratinocytes but was reduced in fibroblasts sur-
rounding the tumors (Figure 7A). CD45+ cells were present in
the dermis adjacent to the epidermal cysts and underlying
the IFE (Figure 7B). b-Catenin stabilization in Lgr6-expressing
stem cells in the upper epidermis stimulated dermal CD26
expression (Figure 7A) and resulted in an increase in CD45+
cells (Figure 7B).
To further investigate the inflammatory response (Arwert et al.,
2012a; Hanahan and Weinberg, 2011) to epidermal b-catenin
activation, we examined expression of the transcription factor
nuclear factor kappa-light-chain-enhancer of activated B cells
(NF-kB) and the macrophage marker F4/80. NF-kB signaling
Figure 7. Inflammatory Response to
Compartmentalized Epidermal b-Catenin
Activation
(A–C) Back skin sections collected from
Ctnnb1lox(ex3)/+ mutant and representative control
(Ctrl) mice 12 (Lgr6 KI), 8 (Lgr5 KI), and 6 weeks
(Lrig1 KI) after 4-OHT application, stained with
antibodies to the markers indicated and counter-
stained with DAPI (blue). Grayscale images show
the same field (A) or higher-magnification views of
selected areas (C). Arrows show lack of staining,
and arrowheads show positive staining in the
stroma. Dashed lines indicate boundary between
epithelium and stroma. Scale bars, 200 mm.
and subsequent recruitment of immune
cells creates a pro-tumorigenic microen-
vironment in skin (Arwert et al., 2010;
Karin, 2009).
In control and Lgr5 KI/R26R-tdTomato/
Ctnnb1lox(ex3)/+ mutant skin, NF-kB and
F4/80 were not detectable in the dermis
(Figure 7C). In contrast, skin from mice
carrying the Ctnnb1 mutant allele with
the Lgr6 KI or Lrig1 KI had strongly
elevated expression of NF-kB in both
epidermis and dermis (Figure 7C).
F4/80+ macrophages were present in
regions of the tumor stroma with high
NF-kB expression (Figure 7C).
In summary, the compartmentalized
induction of epidermal b-catenin trig-
gered different dermal responses, re-
flecting differences in the behavior
of fibroblasts and immune cells. HF
tumors in Lgr5 KI/R26R-tdTomato/
Ctnnb1lox(ex3)/+ mutant skin arose in the absence of inflamma-
tion, while tumors initiated in the permanent portion of the
epidermis of Lgr6 KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ or Lrig1
KI/R26R-tdTomato/Ctnnb1lox(ex3)/+ mice were characterized
by stromal inflammation (Arwert et al., 2012a; Hanahan and
Weinberg, 2011).
DISCUSSION
Here, we show that different epidermal stem cell populations
exhibit different responses to transient or sustained activation
of Wnt/b-catenin. We identify the cells of origin of ectopic HFs
and three different types of epidermal tumor. We show that
different tumor types have a distinct stromal signature, and we
identify the stem cell compartment that gives rise to the ortho-
keratotic interscale IFE in the tail.
By targeting distinct epidermal stem cell compartments in the
lower (hair germ and bulge) and upper PSU (HF isthmus, junc-
tional zone, infundibulum, and SG) and IFE, we traced the cellular
origin of ectopic HFs induced by transient epidermal b-catenin
activation in the SG and orthokeratotic IFE. Ectopic HFs did not
originate from LGR5+ stem cells in the lower HF, even though
Cell Reports 14, 269–281, January 12, 2016 ª2016 The Authors 277
they are b-catenin sensitive (Jaks et al., 2008), and LGR5+ cells in
the newHFs arose fromLGR5- cells, suggesting that ectopic HFs
indeed recapitulate the process of HF development, which has
been proposed previously (Baker et al., 2010; Lo Celso et al.,
2004; Silva-Vargas et al., 2005). Thus, b-catenin-sensitive
LGR5+ cells in the lowerHFwere not redirected to sites of ectopic
HF formation in the epidermal compartments above the bulge.
In contrast, the progeny of LGR6+ and LRIG1+ epidermal stem
cells robustly contributed to ectopic HFs arising from the SG.
None of the new follicles were 100% tdTomato+, demonstrating
that they were polyclonal in origin, as reported previously (Silva-
Vargas et al., 2005). We conclude that b-catenin activation within
the SG causes a direct lineage switch of stem cell progeny from
sebocytes to HF lineages, and tissue compartmentalization is
maintained (F€ullgrabe et al., 2015; Page et al., 2013).
The progeny of LGR6+ stem cells have previously been traced
into the IFE, SG, and upper HF, suggesting that a single pool of
Lgr6-expressing stem cells renews the entire permanent portion
of adult epidermis (Snippert et al., 2010). However, two subse-
quent studies identified scattered Lgr6-EGFP+ cells in multiple
compartments of adult mouse back skin, including the lower
HF, SG, and IFE (Figure 1D) (Liao and Nguyen, 2014; Page
et al., 2013), and a recent study has demonstrated that LGR6+
cells in all these regions contribute to epidermal homeostasis
(F€ullgrabe et al., 2015). We were able to show that ectopic HFs
arising from the IFE are derived from Lgr6-expressing cells in
the interscale of tail IFE (Figures 2H and 2I), strongly suggesting
that LGR6+ cells constitute the interscale stem cell pool (Gomez
et al., 2013). In contrast, the scale IFE of tail skin did not express
Lgr6 (Figure S1). Some of the hair placodes originating from
LGR6+ IFEmatured into hair-shaft-producing HFs that had asso-
ciated SGs, upon activation of the Ctnnb1lox(ex3) mutant allele
(Figure S7A), establishing the competence of the IFE to undergo
HF neogenesis in adult murine back skin.
Tumor formation was readily initiated from all the epidermal
compartments inbackskinupongenetic stabilizationofb-catenin.
Further triggers such wounding or 7,12-dimethylbenz[a]anthra-
cene (DMBA)/12-O-tetradecanoylphorbol 13-acetate (TPA) treat-
ment, as reported for expression of oncogenic K-Ras (Page et al.,
2013), were not required. Compartmentalization was maintained,
such that tumors arising from LGR5+ cells in the lower HF did not
involve theupperHFor IFE, and tumorsof LRIG1+andLGR6+cells
in the upperHF spared the lowerHF.Only in the very late stages of
tumor progression was tissue integrity destroyed as a result of
expansion of the tumor mass.
Deregulated Wnt signaling in skin has previously been associ-
ated with different types of tumors (Klaus and Birchmeier, 2008;
Watt and Collins, 2008). We now show that tumor type depends,
at least in part, on the stem cell compartment in which b-catenin
is activated. LGR5+ cells gave rise to pilomatricomas, while
LRIG1+ cells formed trichoadenomas and LGR6+ cells formed
infundibular cysts in the HF junctional zone and dermatofibro-
mas in the IFE. Although dermatofibromas are characterized
by increased fibroblast density and comprehensive ECM remod-
eling in the reticular dermis, it has been unclear whether these
changes reflect oncogenic changes in the fibroblasts them-
selves or a response to changes in the epidermis (Calonje,
2001; Chen et al., 2000). Our study implicates the epidermis
as the oncogenic target in dermatofibromas. Of note, studies
have shown that some dermatofibromas resemble superficial
BCCs (Zelger et al., 2004), and the b-catenin-induced dermato-
fibromas in our study expressed typical BCC markers such as
K17 and cyclin D1 (Youssef et al., 2012). It has previously been
suggested that BCCs can arise from IFE cells in response to
activating mutations in the Hedgehog (Hh) signaling pathway
(Grachtchouk et al., 2011; Youssef et al., 2010, 2012). Studies
have also shown that b-catenin activation is required for progres-
sion of BCC in human and BCC-like lesions inmice (Pa´lmer et al.,
2008; Youssef et al., 2012).
The oncogenic effects of b-catenin activation in LGR6+ stem
cell subpopulations not only caused different phenotypes de-
pending on their location (IFE, dermatofibromas; HF junctional
zone, infundibular cysts) but also took longer to develop in the
IFE than the HF junctional zone, as recently reported for Hh-
induced BCCs (Peterson et al., 2015). It has been suggested
that the IFE is resistant to Wnt/b-catenin signaling (Watt and
Collins, 2008), since epidermal deletion of b-catenin primarily
affects the HFs and SGs (Huelsken et al., 2001) and ectopic
HFs only arise in the IFE following strong b-catenin activation
(Lo Celso et al., 2004; Silva-Vargas et al., 2005). However, there
is recent evidence that Wnt signaling does control IFE stem cell
proliferation, but its activity is tightly regulated to control the bal-
ance between self-renewal and differentiation of IFE stem cells
(Choi et al., 2013; Lim et al., 2013). This might explain the slow
development of neoplastic lesions in the IFE of Lgr6 KI mice car-
rying the Ctnnb1 activating mutation.
It has previously been shown that epidermal activation of
b-catenin throughout the epidermal stem cell compartment
leads to reprogramming of the dermis to a neonatal state char-
acterized by increased fibroblast density and extensive ECM
remodeling (Collins et al., 2011). The fibroblast lineages of the
upper and lower dermis are responsive to epidermal b-catenin
activity (Driskell et al., 2013), as is the hypodermal adipocyte
layer (Donati et al., 2014). Here, we show that genetic stabiliza-
tion of b-catenin in different epidermal stem cell populations re-
sulted in compartmentalized dermal responses. In each case,
there was a local increase in fibroblast density and transient
ECM remodeling.
Different stromal responses to b-catenin activation in the
different stem cell compartments led to distinct stromal signa-
tures. The influx of inflammatory cells elicited by the LRIG1+
compartment could reflect the expansion of the infundibulum
and associated defects in the epidermal barrier (Chiang et al.,
2013) or activation of b-catenin in LRIG1+ fibroblasts (Gomez
et al., 2013). The different tumor types also had different effects
on CD26 expression: CD26 expression was unchanged when
LGR5+ cells were targeted, was upregulated on targeting of
LGR6+ cells, and was downregulated by targeting LRIG1+ cells.
During skin development, CD26+ fibroblasts reside in the papil-
lary dermis, which provides a permissive microenvironment for
HF induction (Driskell et al., 2013). Upregulation of CD26 also oc-
curs in response to epidermal IL1a and wounding but is downre-
gulated in the stroma of papillomas and SCCs (Arwert et al.,
2012b). It remains to be determined whether the upregulation
of CD26 reflects a selective expansion of the upper dermal
lineage.
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In summary, we have shown that epidermal compartmentali-
zation is sustained during activation of epidermal Wnt/b-catenin
signaling in adult skin. Stem cells differ in their contribution to
ectopic HFs, and stem cell heterogeneity leads to formation
of different tumor types with different stromal composition. Our
study highlights the functional significance of the different
epidermal stem cell populations.
EXPERIMENTAL PROCEDURES
Mice
All animal experiments were subject to institutional ethical review
and performed under the terms of a UK Home Office license.
Ctnnb1lox(ex3)/+, DK5DNb-cateninERt, K19CreERT, Lgr5EGFPiresCreERT2,
Lgr6EGFPiresCreERT2, Lrig5EGFPiresCreERT2, and R26R-tdTomato (Ai9
line) mice have been described previously (Baker et al., 2010; Barker
et al., 2007; Harada et al., 1999; Madisen et al., 2010; Means et al.,
2008; Page et al., 2013; Snippert et al., 2010). For each condition and
time point, three to five mice were treated and analyzed, unless stated
otherwise. Treatment regimes are described in the Supplemental Experi-
mental Procedures.
Histology and Immunohistochemistry
Back and tail skin was fixed overnight in 4% paraformaldehyde (Sigma) and
embedded in paraffin wax. Immunohistochemistry and tail epidermal whole-
mount preparation were performed as described previously (Braun et al.,
2003; Collins et al., 2011; Kretzschmar et al., 2015) and are described in the
Supplemental Experimental Procedures.
Quantification of tdTomato-Positive Ectopic HFs
10–25 pilosebaceous units per tail epidermal whole-mount collected from
each mouse were examined for tdTomato+ ectopic HFs arising from the SG
2 weeks after 4-OHT application. For each mouse the proportion of piloseba-
ceous units containing tdTomato+ cells was calculated. This proportion was
used to calculate the mean average ± SEM from three mice per condition. Sta-
tistical analysis was performed using the unpaired Student’s t test. p values of
less than 0.05 were considered statistically significant.
Quantification of Abnormal Phenotypes
ScannedH&E-stained sections of 25 back skin pilosebaceous units permouse
were examined using Aperio ImageScope software (Leica) for abnormalities in
epidermal subcompartments (IFE, SG, upper HF: infundibulum, junctional
zone and isthmus; lower HF: bulge and hair germ), as described previously
(Youssef et al., 2010). IFE phenotypes were classified as normal, hyperplastic
(increased numbers of cells), dysplastic (abnormal cell morphology) (Youssef
et al., 2010), or dermatofibroma-positive. SG were scored as normal or
abnormal (ectopic HFs and cysts). HF phenotypes were scored in the lower
HF (bulge and hair germ) as normal (anagen versus telogen) following standard
histological guidelines (M€uller-Ro¨ver et al., 2001), cystic (absence of intact hair
shaft), or pilomatricoma positive. The proportion of lesions for each condition
and the proportions of the different types of lesions per epidermal subcom-
partment were calculated from each mouse. This proportion was used to
calculate the mean average ± SEM from three to five mice per condition and
time point, unless stated otherwise.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2015.12.041.
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